New pyrimidine-5-carbonitrile derivatives as EGFR inhibitors with anticancer and apoptotic activities: design, molecular modeling and synthesis

IA Osman, RR Ayyad, HA Mahdy - New Journal of Chemistry, 2022 - pubs.rsc.org
In connection with our efforts in the development of new anticancer agents, herein we report
the design and synthesis of new small pyrimidine-5-carbonitrile based derivatives. The …

Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitors

Y Tu, C Wang, S Xu, Z Lan, W Li, J Han, Y Zhou… - Bioorganic & medicinal …, 2017 - Elsevier
Two series of quinazoline derivatives bearing aryl semicarbazone scaffolds (9a–o and 10a–
o) were designed, synthesized and evaluated for the IC 50 values against four cancer cell …

Structure based design and anti-breast cancer evaluation of some novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor inhibitors

Z Haghighijoo, Z Rezaei, M Jaberipoor… - Research in …, 2018 - journals.lww.com
Quinazoline is one of the most widespread scaffolds amongst natural and synthetic bioactive
compounds. Recently the quinazoline derivatives and in particular the 4-anilinoquinazolines …

Design, synthesis and structure-activity relationships of novel diaryl urea derivatives as potential EGFR inhibitors

N Jiang, Y Bu, Y Wang, M Nie, D Zhang, X Zhai - Molecules, 2016 - mdpi.com
Two novel series of diaryl urea derivatives 5a–i and 13a–l were synthesized and evaluated
for their cytotoxicity against H-460, HT-29, A549, and MDA-MB-231 cancer cell lines in vitro …

Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment

Y Le, Y Gan, Y Fu, J Liu, W Li, X Zou… - Journal of enzyme …, 2020 - Taylor & Francis
In this paper, a series of novel 3-methyl-quinazolinone derivatives was designed,
synthesised and evaluated for antitumor activity in vitro on wild type epidermal growth factor …

Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing oxazole or imidazole as potential EGFR inhibitors

Y OuYang, C Wang, B Zhao, H Xiong, Z Xiao… - New Journal of …, 2018 - pubs.rsc.org
Six series of quinazoline derivatives bearing oxazole or imidazole (8a–f, 9a–f, 10a–d, 11a–f,
12a–d and 13a–i) were designed, synthesized and their IC50 values evaluated against …

Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity

A Sonousi, RA Hassan, EO Osman… - Journal of Enzyme …, 2022 - Taylor & Francis
Abstract Nineteen new quinazolin-4 (3 H)-one derivatives 3a–g and 6a–l were designed
and synthesised to inhibit EGFR. The antiproliferative activity of the synthesised compounds …

Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities …

Y Zhang, Q Wang, L Li, Y Le, L Liu, J Yang… - Journal of Enzyme …, 2021 - Taylor & Francis
In this paper, a set of 3-methylquniazolinone derivatives were designed, synthesised, and
studied the preliminary structure-activity relationship for antiproliferative activities. All target …

Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2, 3-dihydro-indole or 1, 2, 3, 4-tetrahydroquinoline as potential …

Y OuYang, W Zou, L Peng, Z Yang, Q Tang… - European Journal of …, 2018 - Elsevier
Eight series of quinazoline derivatives bearing 2, 3-dihydro-indole or 1, 2, 3, 4-
tetrahydroquinoline were designed, synthesized and evaluated for the IC 50 values against …

Synthesis and evaluation of new 4 (3H)-Quinazolinone derivatives as potential anticancer agents

S Gatadi, G Pulivendala, J Gour, S Malasala… - Journal of Molecular …, 2020 - Elsevier
A series of new 4 (3H)-quinazolinones were synthesized and evaluated for their cytotoxic
activity against a set of human cancer cell lines MDA-MB-231 and MCF-7 (breast), HCT-116 …